| Phytochemical compounds biological activities | Lifetime | 82 | CN 11 | 97.92 |
| Natural product bioactivities and synthesis | Lifetime | 375 | CN 86 | 98.19 |
| Phytochemistry and Biological Activities | Lifetime | 539 | CN 89 | 97.40 |
| Sesquiterpenes and Asteraceae Studies | Lifetime | 124 | CN 9 | 96.59 |
| Traditional and Medicinal Uses of Annonaceae | Lifetime | 285 | CN 23 | 96.28 |
| Natural Compound Pharmacology Studies | Lifetime | 96 | CN 14 | 94.89 |
| Plant chemical constituents analysis | Lifetime | 108 | CN 8 | 94.46 |
| Synthesis of Organic Compounds | Lifetime | 559 | CN 43 | 94.59 |
| Biological Activity of Diterpenoids and Biflavonoids | Lifetime | 383 | CN 67 | 92.24 |
| Phytochemistry and Bioactive Compounds | Lifetime | 375 | CN 72 | 90.60 |
| Plant-derived Lignans Synthesis and Bioactivity | Lifetime | 239 | CN 56 | 90.38 |
| Phytochemistry and Bioactivity Studies | Lifetime | 326 | CN 58 | 88.47 |
| Phytochemicals and Medicinal Plants | Lifetime | 535 | CN 18 | 88.14 |
| Ginger and Zingiberaceae research | Lifetime | 597 | CN 92 | 83.53 |
| Bioactive natural compounds | Lifetime | 911 | CN 193 | 81.93 |
| Andrographolide Research and Applications | Lifetime | 276 | CN 66 | 70.60 |
| Magnolia and Illicium research | Lifetime | 358 | CN 137 | 64.69 |
| Phytochemical compounds biological activities | 2021-2025 | 1 | CN 1 | 98.71 |
| Natural product bioactivities and synthesis | 2021-2025 | 6 | CN 2 | 99.26 |
| Sesquiterpenes and Asteraceae Studies | 2021-2025 | 2 | CN 2 | 98.26 |
| Phytochemistry and Biological Activities | 2021-2025 | 93 | CN 18 | 95.75 |
| Biological Activity of Diterpenoids and Biflavonoids | 2021-2025 | 15 | CN 9 | 91.25 |
| Plant-derived Lignans Synthesis and Bioactivity | 2021-2025 | 13 | CN 9 | 88.61 |
| Natural Compound Pharmacology Studies | 2021-2025 | 20 | CN 12 | 90.26 |
| Traditional and Medicinal Uses of Annonaceae | 2021-2025 | 89 | CN 20 | 87.21 |
| Protein Degradation and Inhibitors | 2021-2025 | 624 | CN 123 | 88.67 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 379 | CN 93 | 86.27 |
| Synthesis of Organic Compounds | 2021-2025 | 72 | CN 23 | 85.95 |
| Phytochemicals and Medicinal Plants | 2021-2025 | 162 | CN 7 | 84.12 |
| Cancer therapeutics and mechanisms | 2021-2025 | 402 | CN 63 | 83.36 |
| Plant biochemistry and biosynthesis | 2021-2025 | 964 | CN 671 | 80.95 |
| PARP inhibition in cancer therapy | 2021-2025 | 881 | CN 91 | 79.38 |
| Carbohydrate Chemistry and Synthesis | 2021-2025 | 476 | CN 127 | 79.85 |
| Bioactive natural compounds | 2021-2025 | 153 | CN 63 | 71.07 |
| Plant Toxicity and Pharmacological Properties | 2021-2025 | 162 | CN 52 | 67.80 |
| Magnolia and Illicium research | 2021-2025 | 174 | CN 107 | 26.40 |
